Several cardiovascular risk factors, such as advanced age and smoking history, are prevalent among lung cancer patients at the time of the diagnosis and increase their risk of future heart disease, ...

Treatment of severe heart failure (HF) across the spectrum of LVEF with the SGLT2 inihbitor dapagliflozin appeared to be safe and effective in reducing the risk of cardiovascular death or worsening HF ...

American Board of Cardiovascular Medicine Chair Jeffrey Kuvin, MD, issued the following statement in response to the American Board of Medical Specialties denial of an independent board for cardiology ...

In patients undergoing PCI for de novo small-vessel coronary artery disease (SV-CAD), paclitaxel-coated balloon (PCB) angioplasty was associated with a reduction in the primary endpoint of major ...

Patients with heart failure (HF) who have worsening HF symptoms that require intensification of oral diuretics in the outpatient setting are common and associated with a poor prognosis, and finerenone ...

JACC: Case Reports is seeking your patient success stories! Share your cases, vignettes and team discussions on patients with failing heart conditions who were ultimately treated successfully. Whether ...

Tafamidis treatment in octogenarians diagnosed with wild-type transthyretin cardiomyopathy (ATTRwt-CM) improves survival without age affecting treatment efficacy, although mortality remains ...

Cardiopulmonary fitness and physical activity levels were significantly lower in children with inherited cardiac disease than in healthy controls, according to a study published Feb. 25 in JAMA ...

Join a community dedicated to innovative cardiovascular care, where every role contributes to our mission of transforming heart health. Explore opportunities that not only advance your career but also ...